10.
nov. 2022
The 9th National Microbiota Conference
We are very happy to welcome you to the 9th National Microbiota Conference on microbiota in health and disease.
The conference will be held at Radisson Blu Scandinavia in Oslo city center
Please click below to register within October 15, 2022!

Agenda

10:00 - 10:05

Marius Trøseid and Johannes Hov
Welcome

10:05 - 10:20

Andraz Nendl
Intestinal fatty acid binding protein is associated with cardiac dysfunction and gut microbiota alterations in chronic heart failure

10:20 - 10:35

Jonas Lundekvam
Proof of concept study; Probiotic intervention in patients with Ulcerative Colitis with insufficient response to anti-TNF treatment

10:35 - 10:50

Line Gaundal
Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels - a randomized controlled trial in healthy individuals

10:50 - 11:20

Keynote Lecturer Peter Holger Johnsen
Update on fecal microbiota transplantation: Where are we - where are we moving

11:20 - 11:45

Break

11:45 - 12:00

Petra Hradicka
Human faecal microbiota transplant in mice (hFMT): how to increase the efficacy to resemble human microbiota composition?

12:00 - 12:15

Ida Rud
Ratio-dependent effect of arabinoxylan and beta-glucan on microbiota and SCFAs during in vitro fermentation

12:15 - 12:30

Polona Rajar
Microbial DNA extraction of high-host content and low biomass samples: optimized protocol for nasopharynx metagenomic studies

12:30 - 12:45

Warren Flood
Development of a high-throughput qPCR platform for precise taxonomic characterization of the human gut microbiome

12:45 - 13:00

Silje Jørgensen
Duodenal inflammation in Common variable immunodeficiency has altered transcriptional response to viruses

13:00 - 14:00

Lunch

14:00 - 14:45

Keynote Lecturer Fredrik Bäckhed
Human Microbiome as a regulator of host physiology and metabolism

14:45 - 15:00

Break

15:00 - 15:15

Ekaterina Avershina
Total neoplastic polyp volume is correlated to several bacterial taxa in faecal immunochemical test-positive CRC-screening patients

15:15 - 15:30

Paula Istvan
Diverse virome in fecal immunochemical tests from bowel cancer screening participants

15:30 - 15:45

Christine Olbjørn
Targeted microbiota profiling, for diagnosis, prognosis and treatment individualization in pediatric inflammatory bowel disease

15:45 - 16:00

Marius Trøseid and Johannes Hov
Closing remarks